Navigation Links
New type of rejection blocker protects kidneys after transplant

UCSF enrolled the first patient to receive belatacept in the trial early in 2001. Twenty UCSF patients have been taking the drug for more than three years. "So far, results are excellent for long-term recipients of the treatment," Vincenti said.

A UCSF immunologist whose research has led to the development of immune tolerance drugs, Jeffrey Bluestone, PhD, put the study in context. "This work underscores the enormous potential of co-stimulatory blockade as a strategy for inducing immune tolerance, not only in transplantation, but in autoimmune diseases as well," Bluestone said. He is UCSF professor of medicine and director of the Immune Tolerance Network (ITN), an NIH-funded international network of more than 80 researchers coordinating clinical testing of new therapies to induce immune tolerance.

"Additionally, this phase II study provides a solid foundation for Dr. Vincenti's upcoming ITN-sponsored study of belatacept in kidney transplant recipients, in which we will test whether true immune tolerance can be achieved," Bluestone said. That new trial, to begin this fall enrolling patients who receive kidney transplants from living donors at UCSF, will test whether transplant patients can be treated with belatacept and can gradually withdraw from all immunosuppressants -- including belatacept itself.

In addition, Bristol-Myers Squibb Company, the pharmaceutical company that developed belatacept, is conducting phase III clinical trials of the drug for kidney transplants. UCSF also is participating in that trial.

RESEARCH RESULTS

Belatacept is an injectable protein, one of a group of experimental drugs called co-stimulatory blockers. The immune system's normal response to a transplant is to recognize the new organ as foreign and to signal production of T-cells poised to destroy it. A second, co-stimulatory signal is required before the T-cells attack the kidney. By blocking this second signal, belatacept prevents de
'"/>

Source:University of California - San Francisco


Page: 1 2 3 4

Related biology news :

1. Simple sea sponge helps scientists understand tissue rejection
2. Researchers identify genes associated with lung transplant rejection
3. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
4. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
5. Proteins may predict lung transplant rejection
6. Survival of heart patients on beta-blockers varies greatly with genetic variation
7. Bound for destruction: Ubiquitination protects against improper Notch signaling
8. Experiments provide proof of how traveling in groups protects insects
9. Experiments provide proof of how traveling in groups protects insects
10. Substance protects resilient staph bacteria
11. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New type rejection blocker protects kidneys after transplant

(Date:7/10/2014)... 10, 2014) Consuming a whole fresh avocado with ... enhanced provitamin A carotenoid (alpha- and beta-carotene) absorption and ... vitamin A, according to new research (1) published ... , Vitamin A is involved in reproductive health ... and vision; and has antioxidant properties. Provitamin A carotenoids, ...
(Date:7/10/2014)... University Medical Center (CUMC) researchers have created a way ... pigmentosa (RP), a leading cause of vision loss. The ... induced pluripotent stem (iPS) cell technology to transform skin ... a patient-specific model for disease study and preclinical testing. ... Tsang, MD, PhD, showed that a form of RP ...
(Date:7/9/2014)... of protein, that,s not why the Millennials are eating it, ... Club Inc.,s annual International Recognition Days convention July 10th in ... want dishes that are quick, easy to cook and that ... care less about any health benefits of Tofu," said lead ... and because it,s quick to cook and it,s filling.", The ...
Breaking Biology News(10 mins):New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2Patient-specific stem cells and personalized gene therapy 2Patient-specific stem cells and personalized gene therapy 3
... the National Center for Supercomputing Applications was barely ... Connection Machines, CM-2, was just being installed, and ... University of Illinois, launched the Theoretical Biophysics Group ... analytical tools of physics and chemistry, coupled with ...
... Heidelberg, Germany, September 17th, 2009 / b3c newswire ... station PROcellcare based on a 96 well plate. ... licensing partner EMBL (European Molecular Biology Laboratory). ... live cells (in vitro) under the microscope with ...
... Researchers at the Department of Biochemistry and Molecular ... revealed the process by which proteins with a ... lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, ... carried out an analysis of their 3D structure ...
Cached Biology News:Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 2Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 3Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 4New Automatic cell feeding station PROcellcare for life cell imaging 2Mechanism related to the onset of various genetic diseases revealed 2Mechanism related to the onset of various genetic diseases revealed 3
(Date:1/15/2014)... , "The interface is the device," Nobel laureate ... properties to be found at the junctures where ... world of nanotechnology, the interfaces between layers of ... in such high-tech favorites as spintronics, high-temperature superconductors, ...
(Date:1/15/2014)... Niagara Thermal Products is proud to announce that ... ("B3") as the critical thermal component supplier in support ... Corps of Engineers.  B3 has developed the only comprehensive ... destroys VOCs and other chemical pollutants, allergens and organic ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... , January 15, 2014 A study ... races on the Formula 1 track could help to tackle ... Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... healthcare provider Simplyhealth. Telemetry technology, which is inspired ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... partnership with Baxa Corporation, announces the, availability of ... laws and regulations related to sterile ... 30 Baxa Corporation announces,the availability of a ... for sterile compounding and USP ,compliance. The ...
... Inc., an innovative provider of advanced neuromodulation products designed to ... HealthSouth Corporation, the nation’s largest provider of inpatient rehabilitative healthcare ... Rehabilitation System and the NESS L300™ Foot Drop System to ... ...
... ALS CLINICALS AND DRUG DEVELOPMENT, ROCKVILLE, Md., ... CUR ) announced that Dr. Thomas Hazel ... Research. He will be,working with Dr. Karl Johe, ... company,s upcoming clinical trial for ALS,(Amytrophic Lateral Sclerosis, ...
Cached Biology Technology:CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements 2CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements 3 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 2 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 3Neuralstem Fills Key Product Development Position 2
... 26] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: